Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties. It acts as a positive allosteric modulator of the GABA-A receptor.
## Primary Indications
* Insomnia (short-term treatment)
* Anxiety disorders
* Preanesthetic medication
* Status epilepticus
## Adult Dosing
* **Insomnia:** 2 mg to 4 mg at bedtime. Maximum dose: 4 mg.
* **Anxiety Disorders:** 1 mg to 2 mg orally 2-3 times daily. Doses may range from 1 mg to 10 mg per day, divided into 2-4 doses.
* **Preanesthetic Medication:** 2 mg to 4 mg intramuscularly or intravenously 2 hours before surgery.
* **Status Epilepticus:** 4 mg administered intravenously or intramuscularly. May be repeated every 5-10 minutes if seizures continue, not to exceed 8 mg in a 12-hour period.
## Pediatric Dosing
* **Status Epilepticus:**
* Intravenous: 0.05 mg/kg (maximum 2 mg) per dose, administered slowly over 2-5 minutes. May be repeated every 5-10 minutes if seizures continue, not to exceed 0.1 mg/kg total or the adult maximum of 4 mg in a 12-hour period.
* Intramuscular: 0.05 mg/kg (maximum 2 mg) per dose.
* **Other indications in pediatrics are not well-established or recommended due to potential for adverse effects.**
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment is routinely recommended, but caution is advised.
* **Geriatric Patients:** Lower doses are generally recommended due to increased sensitivity. Start with 1 mg to 2 mg per day in divided doses.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Significant respiratory depression.
* Severe hepatic or renal impairment (relative contraindication).
* Myasthenia gravis (relative contraindication).
## Adverse Effects
* **Common:** Sedation, dizziness, weakness, unsteadiness, fatigue.
* **Less Common:** Confusion, depression, anterograde amnesia, paradoxical reactions (agitation, excitement), respiratory depression, hypotension.
* **Paradoxical Reactions:** More common in children and the elderly.
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, other sedatives, antihistamines):** Additive CNS depression, leading to profound sedation, respiratory depression, coma, and death.
* **CYP Enzyme Inhibitors/Inducers:** Lorazepam is primarily metabolized by glucuronidation and is not significantly affected by CYP enzymes, making interactions via this pathway less common compared to other benzodiazepines.
## Monitoring
* Level of consciousness, respiratory rate, and oxygen saturation, especially with IV administration or in combination with other CNS depressants.
* Signs of withdrawal upon discontinuation (anxiety, insomnia, irritability, tremor, seizures).
* Cognitive function and sedation, particularly in the elderly.
## Clinical Pearls
* Lorazepam is generally not recommended for long-term use due to the risk of dependence and tolerance.
* Abrupt discontinuation can lead to withdrawal symptoms. Tapering of the dose is recommended.
* Intramuscular administration is generally well-absorbed. Intravenous administration should be given slowly.
* Confusion and paradoxical reactions may be more prominent in elderly patients.
***
**Disclaimer:** This information is intended for clinical professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.
